GO:0004074 biliverdin reductase [NAD(P)H] activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004074 describes the enzymatic activity that converts biliverdin IXalpha to bilirubin IXalpha using NAD(P)H as the electron donor.
• Biliverdin reductase (BVR) is a dual-cofactor enzyme that can utilize both NADH and NADPH, with activity influenced by pH and cofactor availability.
• The enzyme is a major physiologic cytoprotectant, generating the antioxidant bilirubin and contributing to cellular redox balance.
• BVR activity is essential for resistance to malaria, as hypomorphic mutations in biliverdin reductase A define a threshold for bilirubin-mediated anti-malarial protection.
• Structural studies of cyanobacterial BVR reveal that stacked substrate binding is critical for catalytic activity, providing mechanistic insight into the enzyme family.
• BVR is implicated in cancer, neuroprogressive disorders, and renal carcinoma, where its expression and activity are altered.
Description
Biliverdin reductase [NAD(P)H] activity (GO:0004074) is a molecular function that catalyzes the reduction of biliverdin IXalpha to bilirubin IXalpha, using NADH or NADPH as the electron donor and releasing NAD(P)+ and a proton. This reaction is the final step in heme catabolism and is essential for the production of bilirubin, a potent antioxidant and signaling molecule. The enzyme responsible, biliverdin reductase (BVR), exists in multiple isoforms and is highly conserved across species, from cyanobacteria to humans. Researchers study this activity to understand redox homeostasis, cytoprotection, and the pathophysiology of diseases ranging from malaria to cancer and neurodegeneration. The reaction is reversible in vitro, but under physiological conditions, it primarily operates in the reducing direction to generate bilirubin.
biliverdin reductase [NAD(P)H] activity At A Glance
| GO ID | GO:0004074 |
|---|---|
| GO term | biliverdin reductase [NAD(P)H] activity |
| Ontology | molecular_function |
| Synonym | bilirubin:NAD(P)+ oxidoreductase activity; biliverdin reductase [NAD(P)+] activity |
| Definition | Catalysis of the reaction: bilirubin IXalpha + NAD(P)+ = biliverdin IXalpha + NAD(P)H + H+. |
| Major function | Reduction of biliverdin IXalpha to bilirubin IXalpha using NADH or NADPH as electron donor. |
| Cofactors | NADH and NADPH (dual cofactor specificity). |
| Subcellular location | Cytoplasm; also reported in other compartments depending on isoform. |
| Physiological role | Production of bilirubin, a major antioxidant and cytoprotectant. |
What Is GO:0004074?
GO:0004074 is defined as the catalysis of the reaction: bilirubin IXalpha + NAD(P)+ = biliverdin IXalpha + NAD(P)H + H+. In other words, it is the oxidoreductase activity that interconverts biliverdin and bilirubin, using NAD(P)H as the electron donor for the reduction of biliverdin to bilirubin, or NAD(P)+ as the electron acceptor for the reverse oxidation. This activity is synonymous with bilirubin:NAD(P)+ oxidoreductase activity and biliverdin reductase [NAD(P)+] activity.
Why Is biliverdin reductase [NAD(P)H] activity Important in Cell Biology?
Biliverdin reductase [NAD(P)H] activity is critical because it produces bilirubin, a molecule with potent antioxidant and anti-inflammatory properties that protects cells from oxidative stress. This activity is also essential for heme catabolism and iron recycling, and it modulates immune responses, as shown by its role in malaria resistance. Dysregulation of BVR activity has been linked to cancer, neurodegenerative disorders, and renal carcinoma, making it a target for therapeutic intervention and a biomarker for disease progression. Understanding this activity at the molecular level informs studies of redox biology, cellular signaling, and the development of drugs that modulate bilirubin levels.
• Produces bilirubin, a major endogenous antioxidant that scavenges reactive oxygen species.
• Essential for heme catabolism and iron homeostasis.
• Modulates immune responses and is critical for resistance to malaria.
• Altered expression and activity in human renal carcinoma, suggesting a role in cancer.
• Implicated in neuroprogressive disorders through compensatory antioxidant responses.
• Dual cofactor specificity (NADH/NADPH) allows adaptation to cellular redox states.
• Structural insights from cyanobacterial BVR inform drug design and mechanistic studies.
• Potential therapeutic target for conditions involving oxidative stress and inflammation.
• Biliverdin IXβ reductase, a related enzyme, maintains activity via an active site serine, highlighting diversity in the family.
• BVR activity can be inhibited by heavy metals such as mercuric chloride, providing a tool for experimental modulation.
What Happens During biliverdin reductase [NAD(P)H] activity?
Substrate Binding and Cofactor Selection
In simple terms: The enzyme grabs biliverdin and a helper molecule called NADH or NADPH to start the reaction.
Biliverdin reductase binds its substrate, biliverdin IXalpha, in a stacked configuration that is critical for activity, as revealed by the substrate-bound structure of cyanobacterial BVR. The enzyme can utilize both NADH and NADPH as electron donors, with cofactor preference influenced by pH and cellular conditions. This dual specificity allows BVR to function under varying metabolic states.
Catalytic Reduction of Biliverdin to Bilirubin
In simple terms: The enzyme transfers electrons from NADH or NADPH to biliverdin, turning it into bilirubin.
The catalytic mechanism involves hydride transfer from NAD(P)H to biliverdin IXalpha, reducing the biliverdin to bilirubin IXalpha and releasing NAD(P)+ and a proton. This reaction is the final step in heme degradation and is essential for producing bilirubin, a potent antioxidant. The reverse reaction can occur in vitro, but the physiological direction favors bilirubin formation.
Product Release and Cellular Effects
In simple terms: Bilirubin is released and acts as an antioxidant, protecting cells from damage.
Once formed, bilirubin is released from the active site and functions as a major physiologic cytoprotectant, scavenging reactive oxygen species and modulating redox signaling. Bilirubin also has anti-inflammatory and immunomodulatory effects, contributing to cellular protection. The release of NAD(P)+ regenerates the cofactor pool for continued activity.
Regulation by pH and Cofactor Availability
In simple terms: The enzyme's speed changes with acidity and the amount of NADH or NADPH available.
BVR activity is pH-sensitive and cofactor-specific, with studies showing increased activity in renal carcinoma at specific pH and cofactor concentrations. The enzyme's activity can be inhibited by mercuric chloride, indicating that sulfhydryl groups are important for catalysis. These regulatory features allow fine-tuning of bilirubin production in response to cellular demands.
Key Genes Involved in GO:0004074 biliverdin reductase [NAD(P)H] activity
The following genes and proteins are directly associated with biliverdin reductase [NAD(P)H] activity or its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BLVRA | Encodes biliverdin reductase A, the primary enzyme for biliverdin reduction in humans. | Central to bilirubin production and antioxidant defense; mutations linked to malaria resistance. |
| BLVRB | Encodes biliverdin reductase B, which reduces biliverdin IXβ and other substrates. | Maintains activity via active site serine; studied for structural and functional diversity. |
| HMOX1 | Heme oxygenase 1, produces biliverdin from heme. | Upstream of BVR in heme catabolism; regulates bilirubin levels. |
| HMOX2 | Heme oxygenase 2, constitutive isoform producing biliverdin. | Contributes to basal biliverdin supply for BVR activity. |
| NADH | Electron donor for BVR reaction. | Cofactor availability influences enzymatic rate. |
| NADPH | Electron donor for BVR reaction. | Alternative cofactor; supports activity under different redox states. |
| Biliverdin IXalpha | Substrate for BVR. | Direct precursor to bilirubin; levels reflect BVR activity. |
| Bilirubin IXalpha | Product of BVR activity. | Antioxidant and signaling molecule; marker of enzyme function. |
| NAD(P)+ | Oxidized cofactor product. | Regenerated during catalysis; affects cellular redox. |
| Mercuric chloride | Inhibitor of BVR activity. | Used experimentally to probe enzyme mechanism. |
| Serine active site residue | Critical for catalysis in biliverdin IXβ reductase. | Mutation affects activity and stability. |
| Cyanobacterial BVR | Model for structural studies. | Provides insights into substrate stacking and catalysis. |
| NF-κB | Transcription factor potentially regulating BVR expression. | Involved in inflammatory and antioxidant responses. |
| Nrf2 | Master regulator of antioxidant response. | May modulate BVR expression under oxidative stress. |
| Bilirubin | Product with cytoprotective effects. | Modulates immune response and malaria resistance. |
| Heme | Source of biliverdin via heme oxygenase. | Links BVR activity to heme catabolism. |
| Iron | Byproduct of heme catabolism. | Affects cellular redox and BVR regulation. |
| Carbon monoxide | Byproduct of heme oxygenase reaction. | Signaling molecule that may influence BVR. |
How Is biliverdin reductase [NAD(P)H] activity Regulated?
Biliverdin reductase [NAD(P)H] activity is regulated at multiple levels. Enzyme expression can be induced under oxidative stress, as part of the compensatory antioxidant response system involving Nrf2 and NF-κB pathways. Activity is also modulated by pH and cofactor availability, with studies showing pH-dependent and cofactor-specific increases in renal carcinoma. Post-translational modifications and interactions with other proteins may further influence BVR function, although specific mechanisms remain to be fully elucidated. Additionally, the enzyme's activity can be inhibited by heavy metals such as mercuric chloride, suggesting that sulfhydryl groups are critical for catalysis.
biliverdin reductase [NAD(P)H] activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BLVRA | Malaria resistance | Knockout or hypomorphic mutation in cell lines; Plasmodium infection assays. |
| BLVRA | Renal carcinoma | Overexpression in renal cancer cell lines; measure bilirubin and ROS. |
| BLVRB | Enzymatic stability and activity | Point mutation of active site serine; enzymatic assays. |
| HMOX1 | Heme catabolism and oxidative stress | Knockout in hepatocytes; measure biliverdin/bilirubin. |
| NF-κB/Nrf2 | Neuroprogressive disorders | Reporter assays and knockout models for antioxidant response. |
Malaria Resistance
Biliverdin reductase catalytic activity is essential for resistance to malaria, as hypomorphic mutations in biliverdin reductase A define a threshold for bilirubin-mediated anti-malarial protection. This highlights the role of BVR in immune defense and suggests that modulating its activity could influence susceptibility to Plasmodium infection.
Cancer
BVR is induced in human renal carcinoma, with pH and cofactor-specific increases in activity, indicating a potential role in tumor metabolism and antioxidant defense. The enzyme may support cancer cell survival by producing bilirubin, which scavenges reactive oxygen species and protects against oxidative damage.
Neuroprogressive Disorders
The compensatory antioxidant response system, which includes BVR, is implicated in neuroprogressive disorders such as schizophrenia and bipolar disorder. Bilirubin produced by BVR may protect neurons from oxidative stress, but dysregulation could contribute to pathology.
Renal Carcinoma
In human renal carcinoma, BVR activity is increased in a pH- and cofactor-specific manner, suggesting that the enzyme adapts to the tumor microenvironment. This adaptation may provide a survival advantage by enhancing antioxidant capacity.
From biliverdin reductase [NAD(P)H] activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does BLVRA knockout reduce bilirubin production? | CRISPR knockout in HepG2 or HEK293 cells; measure bilirubin by HPLC. |
| How does a point mutation in the active site affect BVR activity? | CRISPR point mutation (e.g., serine to alanine) in BLVRB; enzymatic assays. |
| Can knock-in of a hypomorphic BLVRA allele confer malaria resistance? | Knock-in mouse model or humanized cells; Plasmodium infection. |
| What is the effect of BLVRA overexpression on oxidative stress? | Overexpression in neuronal or renal cells; ROS assays. |
| Where is BVR localized in cells? | Tagged knock-in with GFP; confocal imaging. |
| Can BVR activity be modulated by small molecules? | CRISPR knockout cells complemented with mutant BVR; drug screening. |
How to Study the biliverdin reductase [NAD(P)H] activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay | Biliverdin reduction or bilirubin formation | Enzyme kinetics and inhibitor testing. |
| CRISPR knockout screen | Genes affecting BVR activity or bilirubin levels | Identify regulators of heme catabolism. |
| X-ray crystallography | Three-dimensional structure of BVR-substrate complex | Mechanistic studies and drug design. |
| Mass spectrometry | Biliverdin and bilirubin quantification | Metabolic flux and biomarker discovery. |
| Western blot | BVR protein expression levels | Assess induction under stress. |
| qRT-PCR | BLVRA/BLVRB mRNA levels | Transcriptional regulation studies. |
| ROS assays | Reactive oxygen species levels | Evaluate cytoprotective function. |
| Plasmodium infection assay | Parasite growth in BVR-mutant cells | Malaria resistance studies. |
Enzymatic Activity Assays
Biliverdin reductase activity is typically measured spectrophotometrically by monitoring the decrease in biliverdin absorbance at 670 nm or the increase in bilirubin at 450 nm, using NADH or NADPH as cofactor. These assays can be performed with cell lysates or purified enzyme and are sensitive to pH and cofactor concentration.
CRISPR-Based Genetic Screens
CRISPR knockout or point mutation libraries can be used to identify genes that regulate BVR activity or bilirubin production. For example, a genome-wide knockout screen in cells treated with heme or oxidative stress can reveal modifiers of BVR function.
Structural Biology
X-ray crystallography and cryo-EM of BVR in complex with substrates and cofactors provide mechanistic insights into substrate stacking and catalysis. These methods are essential for understanding how mutations affect enzyme function.
Metabolomics and Flux Analysis
Mass spectrometry-based metabolomics can quantify biliverdin, bilirubin, and related metabolites to assess BVR activity in cells and tissues. Isotope tracing can measure flux through the heme catabolism pathway.
How CRISPR Can Be Used to Study GO:0004074 biliverdin reductase [NAD(P)H] activity
Knockout
CRISPR knockout of BLVRA or BLVRB eliminates biliverdin reductase activity, leading to reduced bilirubin production and increased oxidative stress. These models are used to study the role of BVR in cytoprotection, malaria resistance, and cancer.
Point Mutation
Point mutations in the active site of BVR, such as serine to alanine in BLVRB, can abolish or reduce catalytic activity, allowing structure-function studies. CRISPR point mutation can also recreate hypomorphic alleles associated with malaria resistance.
Knock-in
Knock-in of tagged BVR (e.g., GFP or FLAG) enables localization and interaction studies. Knock-in of disease-associated mutations can model altered enzyme activity in vivo.
Overexpression
Overexpression of BLVRA or BLVRB using CRISPR activation or lentiviral vectors increases bilirubin production and enhances antioxidant capacity. These models are useful for studying the protective effects of BVR in neurodegeneration and cancer.
How EDITGENE Supports biliverdin reductase [NAD(P)H] activity Research
Researchers studying biliverdin reductase [NAD(P)H] activity-related genes often need to determine whether a candidate gene is causally involved in bilirubin production, oxidative stress response, or disease resistance. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for biliverdin reductase [NAD(P)H] activity research.
Frequently Asked Questions About biliverdin reductase [NAD(P)H] activity
What is biliverdin reductase [NAD(P)H] activity?
It is the enzymatic activity that converts biliverdin IXalpha to bilirubin IXalpha using NADH or NADPH as an electron donor, defined by GO:0004074.
What genes are involved in biliverdin reductase [NAD(P)H] activity?
The main genes are BLVRA and BLVRB, which encode biliverdin reductase A and B, respectively.
What is the function of biliverdin reductase?
It produces bilirubin, a potent antioxidant, and plays a key role in heme catabolism and cytoprotection.
How is biliverdin reductase activity measured?
It is typically measured by spectrophotometric assays monitoring biliverdin decrease or bilirubin increase, using NADH or NADPH.
What diseases are associated with biliverdin reductase?
It is linked to malaria resistance, renal carcinoma, and neuroprogressive disorders.
Can biliverdin reductase be inhibited?
Yes, mercuric chloride inhibits its activity, indicating the importance of sulfhydryl groups.
What is the role of biliverdin reductase in malaria?
Biliverdin reductase activity is essential for malaria resistance, as it produces bilirubin which has anti-malarial effects.
How does pH affect biliverdin reductase activity?
Activity is pH-sensitive, with specific pH optima that can shift in cancer cells.
What cofactors does biliverdin reductase use?
It uses both NADH and NADPH as electron donors, with dual specificity.
How can CRISPR be used to study biliverdin reductase?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional studies of BVR in cells and animals.
Conclusion
Biliverdin reductase [NAD(P)H] activity (GO:0004074) is a fundamental enzymatic function that bridges heme catabolism and cellular antioxidant defense. Its product, bilirubin, protects cells from oxidative stress and modulates immune responses, with critical roles in malaria resistance and cancer. Understanding the molecular mechanism, regulation, and disease relevance of this activity requires robust experimental models. EDITGENE's CRISPR services provide the tools to dissect BVR function with precision, from knockout to point mutation and overexpression, enabling researchers to translate basic findings into therapeutic insights.
References
- 1. Mesquita M et al.. 2025. Biliverdin Reductase Catalytic Activity Is Essential for Malaria Resistance.. bioRxiv PMID: 41497634
- 2. Kutty RK et al.. 1983. Biliverdin reductase: characterization in the rat kidney and the inhibition of activity by mercuric chloride.. Biochem Pharmacol 32(13):2095-102 PMID: 6223639
- 3. Takao H et al.. 2017. A substrate-bound structure of cyanobacterial biliverdin reductase identifies stacked substrates as critical for activity.. Nat Commun 8:14397 PMID: 28169272
- 4. Mesquita M et al.. 2026. Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold.. iScience 29(6):115958 PMID: 42199930
- 5. Morris G et al.. 2019. The compensatory antioxidant response system with a focus on neuroprogressive disorders.. Prog Neuropsychopharmacol Biol Psychiatry 95:109708 PMID: 31351160
- 6. Maines MD et al.. 1999. The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma--pH and cofactor-specific increase in activity.. J Urol 162(4):1467-72 PMID: 10492239
- 7. Baranano DE et al.. 2002. Biliverdin reductase: a major physiologic cytoprotectant.. Proc Natl Acad Sci U S A 99(25):16093-8 PMID: 12456881
- 8. Chu WT et al.. 2017. Enzymatic Activity and Thermodynamic Stability of Biliverdin IXβ Reductase Are Maintained by an Active Site Serine.. Chemistry 23(8):1891-1900 PMID: 27897348
